• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于检测11-脱氧-13,14-二氢-15-酮-11,16-环前列腺素E2的灵敏放射免疫分析法:作为人类妊娠和分娩期间前列腺素E2生物合成指标的应用

A sensitive radioimmunoassay for 11-deoxy-13, 14-dihydro-15-keto-11, 16-cyclo-prostaglandin E2: application as an index of prostaglandin E2 biosynthesis during human pregnancy and parturition.

作者信息

Mitchell M D, Ebenhack K, Kraemer D L, Cox K, Cutrer S, Strickland D M

出版信息

Prostaglandins Leukot Med. 1982 Nov;9(5):549-57. doi: 10.1016/0262-1746(82)90036-1.

DOI:10.1016/0262-1746(82)90036-1
PMID:6960378
Abstract

A radioimmunoassay for 11-deoxy-13, 14-dihydro-15-keto-11, 16-cycloprostaglandin E2 (PGEM-II) is described. At pH 10.5, in the presence of albumin, 13, 14-dihydro-15-keto-prostaglandin E2 (PGEM-I) is transformed quantitatively into PGEM-II. Hence, after plasma samples are subjected to this transformation procedure, PGEM-II can be measured in such samples and be a true reflection of PGEM-I production and thereby prostaglandin E2 (PGE2) biosynthesis. The antiserum raised against PGEM-II is minimally cross-reactive with all prostaglandins tested (less than 0.01%). The mean least detectable mass of PGEM-II is 0.8 pg and the mean mass of added PGEM-II required to displace zero-point binding by 50% is 16.6 pg. The assay meets all the standard criteria for accuracy, reproducibility and parallelism. Concentrations of PGEM-II measured by this assay in peripheral plasma from men and nonpregnant women are similar to those reported for PGEM-I after measurements by gas chromatography - mass spectrometry. Plasma concentrations of PGEM-II in men were greater than in nonpregnant women. PGEM-II in increased concentration was found in early pregnancy although concentrations declined in the third trimester until labor when a significant increase was found. Concentrations of PGEM-II in umbilical venous plasma were significantly greater than those in maternal plasma.

摘要

本文描述了一种用于检测11-脱氧-13,14-二氢-15-酮-11,16-环前列腺素E2(PGEM-II)的放射免疫分析方法。在pH 10.5且存在白蛋白的条件下,13,14-二氢-15-酮前列腺素E2(PGEM-I)可定量转化为PGEM-II。因此,血浆样本经过此转化程序后,即可检测其中的PGEM-II,其可真实反映PGEM-I的生成情况,进而反映前列腺素E2(PGE2)的生物合成。针对PGEM-II产生的抗血清与所有检测的前列腺素的交叉反应极小(小于0.01%)。PGEM-II的平均最低检测质量为0.8 pg,使零点结合位移50%所需添加的PGEM-II的平均质量为16.6 pg。该分析方法符合准确性、重复性和平行性的所有标准准则。通过此分析方法测得的男性和未孕女性外周血中PGEM-II的浓度,与气相色谱-质谱法测定PGEM-I后报告的浓度相似。男性血浆中PGEM-II的浓度高于未孕女性。在妊娠早期发现PGEM-II浓度升高,尽管在妊娠晚期直至分娩时浓度下降,但在分娩时发现有显著升高。脐静脉血浆中PGEM-II的浓度明显高于母体血浆中的浓度。

相似文献

1
A sensitive radioimmunoassay for 11-deoxy-13, 14-dihydro-15-keto-11, 16-cyclo-prostaglandin E2: application as an index of prostaglandin E2 biosynthesis during human pregnancy and parturition.一种用于检测11-脱氧-13,14-二氢-15-酮-11,16-环前列腺素E2的灵敏放射免疫分析法:作为人类妊娠和分娩期间前列腺素E2生物合成指标的应用
Prostaglandins Leukot Med. 1982 Nov;9(5):549-57. doi: 10.1016/0262-1746(82)90036-1.
2
Maternal plasma prostaglandin E2 metabolite levels during human pregnancy and parturition.人类妊娠和分娩期间母体血浆前列腺素E2代谢物水平。
Br J Obstet Gynaecol. 1985 Apr;92(4):345-9. doi: 10.1111/j.1471-0528.1985.tb01107.x.
3
Concentration of 13,14-dihydro-15-keto-prostaglandin E2 in the maternal peripheral plasma during labour of spontaneous onset.自然发动分娩期间母体外周血中13,14-二氢-15-酮前列腺素E2的浓度。
Br J Obstet Gynaecol. 1984 Mar;91(3):228-31. doi: 10.1111/j.1471-0528.1984.tb04757.x.
4
Development and validation of a radioimmunoassay for prostaglandin E2 metabolite levels in plasma.血浆中前列腺素E2代谢物水平放射免疫测定法的开发与验证
J Clin Endocrinol Metab. 1983 Jul;57(1):101-6. doi: 10.1210/jcem-57-1-101.
5
Amniotic fluid concentrations of prostaglandin F2 alpha, 13,14-dihydro-15-keto-prostaglandin F2 alpha (PGFM) and 11-deoxy-13,14-dihydro-15-keto-11, 16-cyclo-prostaglandin E2 (PGEM-LL) in preterm labor.早产时羊水前列腺素F2α、13,14-二氢-15-酮-前列腺素F2α(PGFM)和11-脱氧-13,14-二氢-15-酮-11,16-环-前列腺素E2(PGEM-LL)的浓度
Prostaglandins. 1989 Jan;37(1):149-61. doi: 10.1016/0090-6980(89)90038-5.
6
A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.前列腺素E1和E2不稳定肺代谢产物的放射免疫分析:其体内处置和药代动力学的间接指标。
J Pharmacol Exp Ther. 1982 Feb;220(2):229-35.
7
Peripheral prostaglandin metabolite levels in women undergoing therapeutic abortions in the first trimester with and without treatment with prostaglandin synthetase inhibitor.在孕早期接受治疗性流产且使用或未使用前列腺素合成酶抑制剂的女性中,外周前列腺素代谢物水平。
Prostaglandins Leukot Med. 1987 Jun;28(1):53-9. doi: 10.1016/0262-1746(87)90047-3.
8
The radioimmunological estimation of 13, 14-dihydro-15-ketoprostaglandin E2 in plasma and cervical mucus.血浆和宫颈粘液中13,14-二氢-15-酮前列腺素E2的放射免疫测定
Horm Metab Res. 1985 Dec;17(12):685-8. doi: 10.1055/s-2007-1013644.
9
Prostaglandin E2 metabolism by human myometrium.
J Clin Endocrinol Metab. 1988 Feb;66(2):402-7. doi: 10.1210/jcem-66-2-402.
10
Plasma concentrations of prostaglandin F2 alpha and prostaglandin E2 metabolites after transabdominal and transvaginal cervical cerclage.经腹和经阴道宫颈环扎术后前列腺素F2α和前列腺素E2代谢产物的血浆浓度。
Am J Obstet Gynecol. 1987 Jun;156(6):1543-52. doi: 10.1016/0002-9378(87)90029-9.

引用本文的文献

1
Urinary prostaglandin metabolites as biomarkers for human labour: Insights into future predictors.尿前列腺素代谢产物作为人类分娩的生物标志物:对未来预测指标的见解
PLoS One. 2025 Jul 14;20(7):e0315484. doi: 10.1371/journal.pone.0315484. eCollection 2025.
2
Prostaglandins in biofluids in pregnancy and labour: A systematic review.生物流体中的前列腺素在妊娠和分娩中的作用:系统评价。
PLoS One. 2021 Nov 18;16(11):e0260115. doi: 10.1371/journal.pone.0260115. eCollection 2021.
3
The effects of ritodrine on prostaglandin metabolite concentrations in the blood of pregnant baboons.
Arch Gynecol. 1983;234(1):21-6. doi: 10.1007/BF02114720.
4
Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor.人蜕膜中恶病质素/肿瘤坏死因子-α的形成。细胞因子在感染诱导的早产中的潜在作用。
J Clin Invest. 1989 Feb;83(2):430-6. doi: 10.1172/JCI113901.